SOAM
RNAM

SBI Okasan Asset Management’s Avidity Biosciences RNAM Stock Holding History

SBI Okasan Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,100
Closed -$1.02M – 338
2025
Q4 		$1.02M Buy
+14,100
New +$911K 0.06% 114

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

SBI Okasan Asset Management's RNAM Position: Q1 2026 in Review

SBI Okasan Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 14,100 shares — an estimated $1.02M sold.

SBI Okasan Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.02M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • SBI Okasan Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • SBI Okasan Asset Management sold 14,100 Avidity Biosciences shares in Q1 2026, an estimated $1.02M.
  • SBI Okasan Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • SBI Okasan Asset Management's Avidity Biosciences position peaked at $1.02M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on SBI Okasan Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.